Full Text View
Tabular View
No Study Results Posted
Related Studies
Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide
This study is currently recruiting participants.
Study NCT00152932   Information provided by University Health Network, Toronto
First Received: September 8, 2005   Last Updated: July 23, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma
More general conditions related to this trial
Eye Diseases
Ocular Hypertension
Interventions listed in this trial
Dorzolamide 2% drops
HRF and CLBF
Additional drug interventions recognized in this trial
Dorzolamide
More general drug interventions related to this trial
Antihypertensive Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Health Network, Toronto
Merck Frosst Canada Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services